Magnetic resonance spectroscopy in multiple sclerosis;Spectroscopie par résonance magnétique et sclérose en plaques

Revue Neurologique

Volumn 156, Issue 12, 2000, Pages 1078-1086

  Viala, K ^a   Stievenart, J L ^b,c   Cabanis, E A ^b   Lyon Caen, O ^a   Tourbah, A ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

^c BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; INOSITOL; LIPID; N ACETYLASPARTIC ACID;

DEMYELINATION; DIAGNOSTIC ACCURACY; GLIOSIS; HUMAN; INFLAMMATION; MULTIPLE SCLEROSIS; NERVE LESION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PATHOPHYSIOLOGY; REPRODUCIBILITY; REVIEW; WHITE MATTER;

BRAIN; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MULTIPLE SCLEROSIS; SENSITIVITY AND SPECIFICITY;

EID: 0034519854     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (74)

1. Mapping of metabolites in whole animals by 31 P NMR using surbace coil
2. The morbid anatomy of the demyelinative disease
3. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis
4. In vivo determination of multiexponential T2 relaxation in the brain of patients with multiple sclerosis
5. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis
6. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques
7. Proton nuclear magnetic resonance spectra of excised rat brain: Assigment of resonances
8. NMR spectroscopy in neurochemistry
9. Acute stroke evaluation with serial proton MR spectroscopic imaging
10. N-Acetyl-L-Aspartic acid: A literature review of a compound prominent in H-NMR spectroscopic studies of brain
11. Nuclear induction
12. Depth-resolved surface coil spectroscopy (dress) for in vivo 1 H, 31 μP, 13C NMR
13. Multinuclear NMR studies on the energy metabolism of glial and neurons cells
14. The proton NMR spectrum in acute EAE: The significance of the change in the Cho/Cr ratio
15. Multiple sclerosis in children: Cerebral metabolic alterations monitored by localized proton magnetic resonance spectroscopy in vivo
16. Sclérose en plaque, imagerie et spectroscopie par résonnance magnétique
17. Histologie de la sclérose en plaques
18. Clinical applications of proton spectroscopy
19. H1 NMR detection of cerebral myoinositol
20. A relationship of N acetylaspartate biosynthesis to neuronal protein synthesis
21. Clinical MR spectroscopy: Fundamentals, current, applications, and future potential
22. The excitation and depression of spinal neurones by structurally related amino acids
23. Acetate metabolism in the nervous system. N-acetyl-L-aspartic acid and biosynthesis of brain lipids
24. Persistant functional deficit in multiple sclerosis and autosomic dominant cerebellar ataxia is associated with axonal loss
25. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions
26. H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis
27. Chemical pathology of acute demyelinating lesions and its correlation with disability
28. Proteolytic activity and basic protein loss in and around multiple sclerosis plaques: Combined biochemical and histochemical observations
29. Begnin versus secondary progressive multiple sclerosis: The potential rôle of proton MR spectroscopy in defining the nature of disability
30. Axonal damage in acute multiple sclerosis lesions
31. Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: A follow up study
32. A magnetization transfer imaging study of normal appearing white in multiple sclerosis
33. Localized high resolution proton NMR spectroscopy using stimulated echoes: Initial applications to human brain in vivo
34. Localized proton NMR spectroscopy of brain tumors using short echo time STEAM sequences
35. Observation on the histopathology of the cerebral lesion in disseminated sclerosis
36. MR proton spectroscopy in multiple sclerosis
37. Biochemical alterations in multiple sclerosis lesions and normal appearing white matter detected by in vivo 31P and H spectroscpic imaging
38. Magnetic resonance spectroscopy of multiple sclerosis: In vivo detection of myelin breakdown products
39. Development of the human brain: In vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy
40. Spin-lattice relaxation (T1) times of cerebral white matter in multiple sclerosis
41. Proton MR spectroscopy and MR imaging in acute and chronic multiple sclerosis-ringlike appearances in acute plaques
42. Localized in vivo proton spectroscopy in the brain of patients with multiple sclerosis
43. Progressive cerebral atrophy in multiple sclerosis. A serial MRI study
44. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression
45. The pathological and clinical dynamics of multiple sclerosis
46. Studies in the function of N-acetylaspartic acid in brain
47. Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy
48. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis
49. Étude par résonance magnétique nucléaire (RMN) in vivo du métabolisme cérébral
50. Serial proton magnetic resonance spectroscopic imaging, contrast enhanced magnetic resonance imaging and quantitative lesion volumetry in multiple sclerosis
51. Distribution of glial fibrillary acidic protein in gliosed human white matter
52. Synthesis of N-acetyl-L-aspartate by rat brain mithochondria and its involvement in mithochondrial/cytosolic carbon transport
53. Evaluation of multiple sclerosis by H1 spectroscopic imaging at 4,1 T
54. Acute demyelinating disease. Classification and non invasive diagnosis
55. The dependance of nuclear magnetic resonance frequency upon chemical shift
56. Resonance absorption by nuclear magnetic momentsin solids
57. Histamine-dependent formation of N-acetyl-aspartyl peptides in mouse brain
58. Proton MR spectroscopy in multiple sclerosis: Value in establishing diagnosis, monitoring progression, and evaluation therapy
59. H-MRS in patients with multiple sclerosis undergoing treatment with interferon béta 1a: Results of a preliminary study
60. Immunocytochemical localization of Acetyl-aspartate with monoclonal antibodies
61. De la résonance magnétique nucléaire RMN, à l'imagerie (IRM), l'angiographie (ARM), l'imagerie fonctionnelle, et la spectroscopie
62. Conditions pour une biométrie en spectroscopie du proton in vivo
63. Neuropathies optiques inflammatoires, SEP et maladies démyélinisantes, IRM et SRM
64. In vivo localized NMR proton spectroscopy of normal appearing white matter in patients with multiple sclerosis
65. Localized proton MR spectroscopy in relapsing remitting vs secondary progressive multiple sclerosis
66. Axonal transection in the lesions of multiple sclerosis
67. Specific expression of N-acetyl aspartate in neurons, oligodendrocyte-type2 astrocyte progenitor, and immature oligodendrocytes in vitro
68. Human brain proton localized NMR spectroscopy in multiple sclerosis
69. Correlating MRI and clinical desease activity in multiple sclerosis: Relevance of hypointense lesions on short TR: Short TE (T1 weighted spin echo images)
70. Proton magnetic resonance spectroscopy in multiple sclerosis
71. Techniques de localisation en spectroscopie RM in vivo